Replies to post #224075 on Biotech Values

[rfj1862]

MRKR

I am and I own it. I just did my end of day look at my stocks and was wondering why MRKR suddenly got a close to 10% bump. While I'm pleased of course I'm also disconcerted that a Seeking Alpha article written by an amateur can have this result.

I've done extensive work on CAR-T cells, almost from the beginning, and this technology is extraordinarily impressive. My thought is that it is a prime candidate for a very early takeout, probably at a high premium since it is so cheap right now.

Also I'd say that if you are going to take a larger position, do so before the pancreatic data at ASCO.



https://seekingalpha.com/article/4249159-marker-therapeutics-phenomenal-data-lymphoma-indications-yet-little-recognition-street